FEATURED SEARCH: plantibodies
Many experiments have confirmed that plants can make recombinant peptides that act as antigens to induce pronounced immune responses, according to this review. But although the idea is attractive from the point of view of safety and ease of production, regulatory and technical hurdles have slowed progress to date. The regulatory situation has improved, and improvements in production are ready to move from academia to industry, says the author, a biotechnologist with Thomas Jefferson University.
RESULT: Plant biotechnology for production of recombinant pharmaceuticals
Human Vaccines | Jul 8, 2011 (FREE FULL TEXT)
Most often, plant-based vaccines are discussed as a solution for infectious diseases in developing countries. But they could also prove useful for more costly conditions in countries such as the United States, to judge from the following report.
RESULT: Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma
Annals of Oncology | May 21, 2010 (FREE FULL TEXT)